Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mallat

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Cytochrome P-450IIIA, cyclosporine and drug interactions]A Mallat
Gastroenterologie Clinique Et Biologique|October 26, 1999
[Drug-induced hepatitis: diagnosis and treatment]A Mallat
Digestion|August 7, 1998
Hepatic stellate cells and intrahepatic modulation of portal pressureA Mallat
Journal of Endocrinological Investigation|June 6, 2006
Endocannabinoids as novel mediators of liver diseasesA Mallat, S Lotersztajn
Journal of Hepatology|September 1, 1996
Multiple hepatic functions of endothelin-1: physiopathological relevanceA Mallat, S Lotersztajn
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Endocannabinoids and their role in fatty liver diseaseA Mallat, S Lotersztajn
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 3, 2007
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liverA Mallat, S Lotersztajn
Journal of Hepatology|January 1, 1995
Perspectives in the treatment of liver fibrosisP Mavier, A Mallat
Gastroenterologie Clinique Et Biologique|November 10, 2009
[Comorbidity and hepatotoxicity of tobacco and recreational substances]C Hezode, A Mallat
Gastroenterologie Clinique Et Biologique|June 30, 2009
[Liver fibrosis: from pathophysiology to therapeutic openings]A Mallat, S Lotersztajn
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Cytochrome P-450IIIA, cyclosporine and drug interactions]A Mallat
Gastroenterologie Clinique Et Biologique|October 26, 1999
[Drug-induced hepatitis: diagnosis and treatment]A Mallat
Digestion|August 7, 1998
Hepatic stellate cells and intrahepatic modulation of portal pressureA Mallat
Journal of Endocrinological Investigation|June 6, 2006
Endocannabinoids as novel mediators of liver diseasesA Mallat, S Lotersztajn
Journal of Hepatology|September 1, 1996
Multiple hepatic functions of endothelin-1: physiopathological relevanceA Mallat, S Lotersztajn
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Endocannabinoids and their role in fatty liver diseaseA Mallat, S Lotersztajn
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 3, 2007
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liverA Mallat, S Lotersztajn
Journal of Hepatology|January 1, 1995
Perspectives in the treatment of liver fibrosisP Mavier, A Mallat
Gastroenterologie Clinique Et Biologique|November 10, 2009
[Comorbidity and hepatotoxicity of tobacco and recreational substances]C Hezode, A Mallat
Gastroenterologie Clinique Et Biologique|June 30, 2009
[Liver fibrosis: from pathophysiology to therapeutic openings]A Mallat, S Lotersztajn
Pageof 7